Sanofi strengthens efforts to prevent Chronic Respiratory Diseases in UAE

The Ministry of Health and Prevention (MoHAP) in the UAE has signed a Memorandum of Understanding (MoU) with Sanofi...

August 9, 2025 | Saturday | News
Astria licenses rare disease drug Navenibart to Japan’s Kaken Pharma in $32 M deal

Astria Therapeutics, Inc. a US-based biopharmaceutical company, has exclusively licensed development and commercial...

August 8, 2025 | Friday | News
Korea's Celltrion receives US FDA approval of expanded indication for AVTOZMA

South Korea-based Celltrion, Inc. has announced that the US Food and Drug Administration (FDA) has approved an expanded ...

August 9, 2025 | Saturday | News
India's Intas Pharma emerges as largest global supplier of Pegfilgrastim with acquisition of UDENYCA

India-based Intas Pharmaceuticals, in collaboration with its global subsidiaries operating under the Accord brand, has s...

August 7, 2025 | Thursday | News
Everest Medicines receives full approval of NEFECON in Taiwan for nephropathy treatment

Everest Medicines, a China-based biopharmaceutical company focused on the discovery, clinical development, manufacturing...

August 6, 2025 | Wednesday | News
Arrowhead sells rights of Hypertriglyceridemia candidate to Sanofi in Greater China for $265 M

Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Ther...

August 5, 2025 | Tuesday | News
Viridian Therapeutics and Kissei Pharma ink deal worth $315 M focusing on thyroid eye disease in Japan

Viridian Therapeutics, Inc., a US-based biopharmaceutical company focused on discovering, developing, and commercialisin...

July 30, 2025 | Wednesday | News
Dr. Falk Pharma and Allianthera (Suzhou) Biopharma to develop treatment for Ulcerative Colitis

Dr. Falk Pharma GmbH, a Germany-headquartered research-based pharmaceutical company specialising in digestive and metabo...

July 30, 2025 | Wednesday | News
Asahi Kasei expands Planova production with new spinning plant in Japan

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, has announced plans to construct a ...

July 29, 2025 | Tuesday | News
The Future Formula: What’s Driving Recruitment Innovation in Pharma

The pharmaceutical and life sciences industry has been undergoing a transformation driven by rapid technological change,...

August 2, 2025 | Saturday | Opinion
“ASEAN has become an important fulcrum in the global pharmaceutical production supply chain”

What are your plans for capacity expansion in biologics and ADC manufacturing? We are already among the largest biologi...

August 2, 2025 | Saturday | Opinion
"HSA is adopting a forward-looking 5P Strategy to tackle challenges”

Presently, what are HSA’s key priorities that align with positioning Singapore as a regional hub for biotech and m...

August 2, 2025 | Saturday | Opinion
Australia searches for the next CSL

Australian biotech is known for its cutting-edge research, robust clinical trial activity, and favourable R&D infras...

August 2, 2025 | Saturday | Analysis
APAC building on enough supply network for radiopharmaceuticals

Global interest in radiopharmaceuticals has surged in recent years, driven by a string of high-profile deals and rising ...

August 2, 2025 | Saturday | Analysis
GSK partners with China's Hengrui Pharma in $12 B deal for 12 innovative medicines

GSK plc has entered into agreements with China-based Hengrui Pharma to develop up to 12 innovative medicines, adding sig...

July 29, 2025 | Tuesday | News
Colorcon announces opening of new manufacturing facility in Malaysia

Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled ...

July 28, 2025 | Monday | News
Biocon Biologics launches Nepexto, a Biosimilar to Enbrel (Etanercept), in Australia

India's Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has laun...

July 25, 2025 | Friday | News
MilliporeSigma and Washington University sign MoU to advance scientific collaboration

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technol...

July 25, 2025 | Friday | News